| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/07/2000 | CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound |
| 06/07/2000 | CN1255377A Stable recombinational human interferon preparation |
| 06/07/2000 | CN1255374A Medicine for curing diseases in nerve system and its preparing process |
| 06/07/2000 | CN1053197C Extracting process for flammulin essence |
| 06/07/2000 | CN1053188C Quinolizinone type compounds |
| 06/07/2000 | CN1053117C Processes for prepn. of compsns. used in treatment of kaposi |
| 06/06/2000 | US6072072 Compounds which stabilize hemoglobin and modify oxygen affinity; blood substitutes |
| 06/06/2000 | US6072049 Hepatitis B surface antigen vaccine |
| 06/06/2000 | US6072048 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 06/06/2000 | US6072047 Nucleotide and amino acid sequence that binds the protein known as tumor necrosis factor-related apoptosis-inducing ligand; for recombinant expression; for purifying protein or suppressing activities |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6072037 Antibodies to the IL-17 receptor |
| 06/06/2000 | US6072036 Antibody containing a secretory signal and an intracellular retention sequence; for genetically engineered expression inside cells; for antitumor/anticarcinogenic agents and viricides |
| 06/06/2000 | US6072035 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 06/06/2000 | US6072034 Nucleotide and amino acid sequences of protein found in breast and ovarian cancer; diagnosis; anticarcinogenic agents; for screening drugs |
| 06/06/2000 | US6072033 Receptor that binds IL-17 |
| 06/06/2000 | US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections |
| 06/06/2000 | US6072031 Amino acid sequences of human protein; for diagnosis of cancer and anticarcinogenic agents |
| 06/06/2000 | US6072030 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 06/06/2000 | US6072029 Derivatives of human α1 -antitrypsin and process for their preparation |
| 06/06/2000 | US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease |
| 06/06/2000 | US6071965 Phosphinic alkanoic acid derivatives |
| 06/06/2000 | US6071956 Treatment of tissues to reduce subsequent response to injury |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071942 Elevation of circulating blood histamine levels |
| 06/06/2000 | US6071914 Comparing the prolactin profile of a mammal to a standard prolactin profile for healthy mammals of the same species and sex and adjusting the prolactin profile of the afflicted mammal to conform to the standard; circadian rhythm rhythms |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/06/2000 | US6071894 Sensor histidine kinase of Staphylococcus aureus |
| 06/06/2000 | US6071893 Administering to the mammal a polynucleotide encoding a fusion glycoprotein of respiratory syncytial viurs in combination with an effective amount of adjuvant interleukin-12 for reducing replication of respiratory syncytial virus |
| 06/06/2000 | US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein |
| 06/06/2000 | US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition |
| 06/06/2000 | US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells |
| 06/06/2000 | US6071882 Administering an effective synergistic amount of leuteinizing hormone releasing hormone antagonist cetrorelix in combination with alpha-receptor blocking agents to treat the prostate hypertrophy and prostate cancer |
| 06/06/2000 | US6071881 A peptide havig growth promotion effects and activity promotion effects on osteoblasts |
| 06/06/2000 | US6071880 Use of IGF-I for the treatment of renal insufficiencies, steriod toxicity and related indications |
| 06/06/2000 | US6071879 Method for the treatment of bacterial infection |
| 06/06/2000 | US6071876 Administering to a patient a superoxide dismutase, or superoxide dimutase mimic and catalase to enhance central nervous system absorption and efficacy. |
| 06/06/2000 | US6071875 TGFα for the treatment of ocular hypertension and glaucoma |
| 06/06/2000 | US6071874 Human pathogenesis-related protein |
| 06/06/2000 | US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins |
| 06/06/2000 | US6071743 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/06/2000 | US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines |
| 06/06/2000 | US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents |
| 06/06/2000 | US6071730 Cell ablation using trans-splicing ribozymes |
| 06/06/2000 | US6071723 Inhibitors of human plasmin derived from the Kunitz domains |
| 06/06/2000 | US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
| 06/06/2000 | US6071721 Calcium binding protein |
| 06/06/2000 | US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents |
| 06/06/2000 | US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections |
| 06/06/2000 | US6071717 Polycystic kidney disease gene and protein |
| 06/06/2000 | US6071715 Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
| 06/06/2000 | US6071710 Antikinin compounds and uses thereof |
| 06/06/2000 | US6071709 Nerve growth factor/receptor complex |
| 06/06/2000 | US6071708 Morphogenic protein compositions of matter |
| 06/06/2000 | US6071707 Phosphotyrosine mimics and method for identifying and using same |
| 06/06/2000 | US6071704 Human aflatoxin B1 aldehyde reductase |
| 06/06/2000 | US6071703 Detecting polynucleotide sequence which codes human transport proteins; hybridizing nucleic acids probes to nucleic acids of sample and detecting hybridization products |
| 06/06/2000 | US6071701 Detecting polynucleotide sequences which code polypeptide associated with inflammation; contacting nucleic acids with a polynucleotide sequence which codes inflammation polypeptide, allowing hybridization, detecting hybridization products |
| 06/06/2000 | US6071697 Method for testing the differentiation status in pancreatic cells of a mammal |
| 06/06/2000 | US6071696 Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation |
| 06/06/2000 | US6071693 HCV genomic sequences for diagnostics and therapeutics |
| 06/06/2000 | US6071593 Ceramic packing with channels for thermal and catalytic beds |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/06/2000 | US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery |
| 06/06/2000 | US6071522 Cloning of mite allergens |
| 06/06/2000 | US6071520 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 06/06/2000 | US6071518 GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium |
| 06/06/2000 | US6071515 Dimer and multimer forms of single chain polypeptides |
| 06/06/2000 | US6071514 Administering activated protein c and antiplatelet agent and/or anticoagulant |
| 06/06/2000 | US6071513 Human glutathione-S-transferase |
| 06/06/2000 | US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence |
| 06/06/2000 | US6071510 Modified amino acids and compositions comprising the same for delivering active agents |
| 06/06/2000 | US6071509 Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 06/06/2000 | US6071497 Microparticles for lung delivery comprising diketopiperazine |
| 06/06/2000 | US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled |
| 06/06/2000 | CA2203627C Rapid detection and identification of nucleic acid variants and pathogens |
| 06/06/2000 | CA2157925C Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
| 06/06/2000 | CA2130988C Pharmaceutical composition for treatment of sudden deafness |
| 06/06/2000 | CA2057896C Biologically active polypeptides based on transformed growth factor-beta sequences |
| 06/06/2000 | CA1341017C Use of growth hormone releasing factor for improving mental function |
| 06/06/2000 | CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 06/06/2000 | CA1341012C Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
| 06/02/2000 | WO2000031532A1 Methods of identifying viral therapeutics |
| 06/02/2000 | WO2000031302A1 In situ binary synthesis of biologically effective molecules |
| 06/02/2000 | WO2000031296A1 Antisense modulation of interleukin-15 expression |
| 06/02/2000 | WO2000031290A1 Methods and compositions for pain management |
| 06/02/2000 | WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 06/02/2000 | WO2000031279A2 Producing antimicrobial cationic peptides as fusion proteins |
| 06/02/2000 | WO2000031271A1 Hiv infection inhibitors |
| 06/02/2000 | WO2000031267A1 Insulin production by engineered muscle cells |
| 06/02/2000 | WO2000031266A1 Human parathyroid hormone modifications, preparation and use |
| 06/02/2000 | WO2000031265A1 Urotensins ii of mammals and their uses |
| 06/02/2000 | WO2000031264A2 Testis-specific cystatin-like protein cystatin t |
| 06/02/2000 | WO2000031263A2 Gtpase associated proteins |
| 06/02/2000 | WO2000031254A2 Apoptosis-inducing factor |
| 06/02/2000 | WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 06/02/2000 | WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof |
| 06/02/2000 | WO2000031243A1 Novel serine protease bssp5 |